| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Recent developments in Amgen's product/service offerings, particularly with MariTide, reveal a mixed outlook. While there are enhancements in trial design that could bolster market acceptance, significant skepticism about the product's efficacy in treating obesity and type 2 diabetes looms heavily. The investor sentiment is notably weighed down by doubts, impacting overall confidence in product development. Thus, the landscape is shaped by both cautious optimism and prevalent concerns. |
| The price action of Amgen (AMGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for AMGN since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.2, and the negative at -0.2 on 2025-09-25. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (0.9) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| AMGN | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-25 | 0%(0%) | 0 | 0% | -0 | 0.9 | -1 | |||||||
| 2025-09-24 | 0%(0%) | 0 | 0% | 0.2 | 2.4 | -1 | |||||||
| 2025-09-23 | 0%(0%) | 0 | 0% | 0.3 | 3 | -1 | |||||||
| 2025-09-22 | 0%(0%) | 0 | 0% | 0.4 | 3.5 | -1 | |||||||
| 2025-09-21 | 0%(0%) | 0 | 0% | 0.4 | 3.1 | -1 | |||||||
| 2025-09-20 | 0%(0%) | 0 | 0% | 0.4 | 3.4 | -1 | |||||||
| 2025-09-18 | 0%(0%) | 0 | 0% | 0.4 | 3.4 | -1 | |||||||
| 2025-09-14 | 0%(0%) | 0 | 0% | 0.2 | 2 | -1 | |||||||
| 2025-09-10 | 0%(0%) | 0 | 0% | 0.2 | 2 | -1 | |||||||
| 2025-06-24 | 0%(0%) | 0 | 0% | 0.1 | 1.3 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-09-25 18:06:18 Increased competition in the obesity and diabetes treatment markets raises concerns for Amgen's positioning and long-term success. |
| 2025-09-25 18:06:18 Analysts indicate a generally cautious outlook on Amgen due to past performance and ongoing investor skepticism. |
| 2025-09-25 18:06:18 Potential enhancements in the trial design of MariTide are seen as a positive factor that could improve its market acceptance. |
| 2025-09-25 18:06:18 Investors express doubts regarding MariTide's effectiveness in treating obesity and type 2 diabetes, affecting overall sentiment on product development. |
| 2025-09-25 18:06:18 Articles highlight the recent decline in Amgen's stock value, reflecting concerns among investors. |